StonvexLoading…
StonvexStonvexStonvexCore line items from SYNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-28 | Annual 2024 2024-06-29 | Annual 2023 2023-06-24 | Annual 2022 2022-06-25 |
|---|---|---|---|---|
Revenue | $1.07B | $959.40M | $1.36B | $1.74B |
Operating Income | $-94.10M | $-101.60M | $154.30M | $350.40M |
Net Income | $-47.80M | $125.60M | $73.60M | $257.50M |
EPS (Diluted) | $-1.22 | $3.16 | $1.83 | $6.33 |
Total Assets | $2.58B | $2.83B | $2.61B | $2.86B |
Total Liabilities | $1.19B | $1.36B | $1.37B | $1.59B |
Cash & Equivalents | $391.50M | $876.90M | $924.70M | $824.00M |
Free Cash Flow OCF − CapEx | $116.20M | $102.10M | $297.30M | $431.60M |
Shares Outstanding | 38.64M | 39.57M | 38.57M | 39.62M |